4.8 Letter

Polypill Strategy in Secondary Cardiovascular Prevention

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 387, 期 23, 页码 2196-2198

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2213446

关键词

-

向作者/读者索取更多资源

In the SECURE trial, it was found that the use of a polypill containing aspirin, ramipril, and atorvastatin significantly reduced the risk of cardiovascular events in older patients with recent myocardial infarction. However, the absence of beta-blockers in this polypill raised questions as these drugs have been known to be effective after myocardial infarction and are recommended in current guidelines.
To the Editor: In their article on the Secondary Prevention of Cardiovascular Disease in the Elderly (SECURE) trial, Castellano et al. (Sept. 15 issue)(1) report that treatment with a polypill containing aspirin, ramipril, and atorvastatin was associated with a significantly lower risk of cardiovascular events than usual care in older patients with recent myocardial infarction. However, this polypill did not contain a beta-blocker, although it is has been known for decades that these drugs are particularly effective after myocardial infarction(2,3) and their use is recommended in current guidelines.(4,5) Therefore, can the SECURE investigators report data to answer the question of . . .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据